117 related articles for article (PubMed ID: 8685082)
1. BB-882 is a potent antagonist of the haemodynamic changes induced by platelet-activating factor in pigs.
Abu-Zidan FM; Walther S; Lennquist S
Pharmacol Toxicol; 1996 Jan; 78(1):23-7. PubMed ID: 8685082
[TBL] [Abstract][Full Text] [Related]
2. Role of platelet-activating factor antagonism in posthemorrhage septic shock in pigs.
Abu-Zidan FM; Walther S; Lennquist S
J Trauma; 1996 Oct; 41(4):634-40. PubMed ID: 8858021
[TBL] [Abstract][Full Text] [Related]
3. Platelet activating factor antagonism improves cardiovascular function in non-hypotensive sepsis in pigs.
Abu-Zidan FM; Walther S
Eur J Surg; 1996 Jun; 162(6):499-504. PubMed ID: 8817228
[TBL] [Abstract][Full Text] [Related]
4. The platelet-activating factor antagonist BB-882 does not improve tissue oxygen extraction in endotoxic shock.
Spapen H; Zhang H; Verhaeghe V; Smail N; Vincent JL
J Crit Care; 1998 Jun; 13(2):81-90. PubMed ID: 9627275
[TBL] [Abstract][Full Text] [Related]
5. Role of platelet-activating factor antagonism in haemorrhagic shock in pigs.
Abu-Zidan FM; Walther S; Lennquist S
Eur Surg Res; 1995; 27(6):379-88. PubMed ID: 8542923
[TBL] [Abstract][Full Text] [Related]
6. Treatment with a platelet-activating factor antagonist has little protective effects during endotoxic shock in the dog.
Spapen H; Zhang H; Verhaeghe V; Rogiers P; Cabral A; Vincent JL
Shock; 1997 Sep; 8(3):200-6. PubMed ID: 9377167
[TBL] [Abstract][Full Text] [Related]
7. Modulation of lung injury by platelet-activating factor antagonism in nonhypotensive porcine endotoxemia.
Abu-Zidan FM; Walther S; Lennquist S
Circ Shock; 1994 Nov; 44(3):148-53. PubMed ID: 7600638
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of endotoxin-induced pathophysiology by a new potent PAF receptor antagonist.
Kruse-Elliott KT; Albert DH; Summers JB; Carter GW; Zimmerman JJ; Grossman JE
Shock; 1996 Apr; 5(4):265-73. PubMed ID: 8721386
[TBL] [Abstract][Full Text] [Related]
9. Effects of a paf-receptor antagonist on hemodynamics during and after cardiopulmonary bypass.
Nathan N; Mercury P; Denizot Y; Cornu E; Laskar M; Lathelize M; Arnoux B; Feiss P
J Cardiothorac Vasc Anesth; 1995 Dec; 9(6):647-52. PubMed ID: 8664454
[TBL] [Abstract][Full Text] [Related]
10. A triazolodiazepine platelet activating factor receptor antagonist (WEB 2086) reduces pulmonary dysfunction during endotoxin shock in swine.
Siebeck M; Weipert J; Keser C; Kohl J; Spannagl M; Machleidt W; Schweiberer L
J Trauma; 1991 Jul; 31(7):942-9; discussion 949-50. PubMed ID: 1906548
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor modulates pulmonary vasomotor tone in the perinatal lamb.
Ibe BO; Hibler S; Raj JU
J Appl Physiol (1985); 1998 Sep; 85(3):1079-85. PubMed ID: 9729586
[TBL] [Abstract][Full Text] [Related]
12. Lexipafant (BB-882), a potent PAF antagonist in acute pancreatitis.
Curtis LD
Adv Exp Med Biol; 1996; 416():361-3. PubMed ID: 9131174
[No Abstract] [Full Text] [Related]
13. Role of platelet-activating factor on cardiovascular dysfunction in postischemic shock in pigs.
Abu-Zidan FM; Walther S; Lennquist S
Eur Surg Res; 1997; 29(2):133-41. PubMed ID: 9058081
[TBL] [Abstract][Full Text] [Related]
14. Fetal pulmonary vasodilation after exogenous platelet-activating factor.
Accurso FJ; Abman SH; Wilkening RB; Worthen GS; Henson P
J Appl Physiol (1985); 1991 Feb; 70(2):778-87. PubMed ID: 2022570
[TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor: evidence against a role in hypoxic pulmonary vasoconstriction.
McCormack DG; Barnes PJ; Evans TW
Crit Care Med; 1990 Dec; 18(12):1398-402. PubMed ID: 2245615
[TBL] [Abstract][Full Text] [Related]
16. Effects of PAF and BN 52021 on cardiac function and regional blood flow in conscious rats.
Sirén AL; Feuerstein G
Am J Physiol; 1989 Jul; 257(1 Pt 2):H25-32. PubMed ID: 2546449
[TBL] [Abstract][Full Text] [Related]
17. Quantitative assessment of increased airway microvascular permeability to 125I-labelled plasma fibrinogen induced by platelet activating factor and bradykinin.
Pedersen KE; Rigby PJ; Goldie RG
Br J Pharmacol; 1991 Sep; 104(1):128-32. PubMed ID: 1664758
[TBL] [Abstract][Full Text] [Related]
18. Regional haemodynamic effects of platelet activating factor in the rat.
King KA; Lim SL; Pang CC
Eur J Pharmacol; 1995 Aug; 281(2):187-93. PubMed ID: 7589206
[TBL] [Abstract][Full Text] [Related]
19. In vivo enhancement of platelet activating factor-induced prostacyclin production by OKY-046, a selective inhibitor of thromboxane A2 synthase.
Davenport NJ; Goldstein RE; Feuerstein GZ
J Cardiovasc Pharmacol; 1991 Apr; 17(4):641-6. PubMed ID: 1711633
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of action of platelet activating factor in the pulmonary circulation: an investigation using a novel isotopic system in rabbit isolated lung.
Seale JP; Nourshargh S; Hellewell PG; Williams TJ
Br J Pharmacol; 1991 Sep; 104(1):251-7. PubMed ID: 1786514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
